| 05/07/2026 7:10 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2026 7:15 AM | Prime Medicine (1894562) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/23/2026 7:53 AM | Prime Medicine (1894562) Filer | Form ARS | |
| 04/23/2026 7:38 AM | Prime Medicine (1894562) Filer | Form DEFA14A | |
| 04/23/2026 7:35 AM | Prime Medicine (1894562) Filer | Form DEF 14A | |
| 04/17/2026 7:25 PM | Makhni Svetlana Ni (2129497) Reporting Prime Medicine (1894562) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/17/2026 7:26 PM | Makhni Svetlana Ni (2129497) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:15 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 11:15 PM | Prime Medicine (1894562) Filer | Form EFFECT | |
| 03/03/2026 7:32 AM | Prime Medicine (1894562) Filer | Form POS AM | |
| 03/03/2026 7:41 AM | Prime Medicine (1894562) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for PRME and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/03/2026 7:13 AM | Prime Medicine (1894562) Filer | Form POSASR | |
| 03/03/2026 7:19 AM | Prime Medicine (1894562) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/03/2026 7:02 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/24/2026 3:58 PM | Alenson Carman (1688865) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 9:28 AM | Prime Medicine (1894562) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
| 01/12/2026 7:31 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 11:18 AM | Prime Medicine (1894562) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G | |
| 11/12/2025 3:30 PM | GV 2019, L.P. (1845041) Filed by Prime Medicine (1894562) Subject | Form SCHEDULE 13G/A | |
| 11/07/2025 7:05 AM | Prime Medicine (1894562) Filer | Form S-3ASR | |
| 11/07/2025 6:27 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/07/2025 6:35 AM | Prime Medicine (1894562) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 10:44 AM | FMR LLC (315066) Filed by Prime Medicine (1894562) Subject | Form SCHEDULE 13G/A | |
| 09/08/2025 7:04 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/11/2025 8:48 PM | ARCH Venture Fund XII, L.P. (1906837) Filed by Prime Medicine (1894562) Subject | Form SCHEDULE 13D/A | |
| 08/07/2025 7:33 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2025 7:36 AM | Prime Medicine (1894562) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2025 7:42 PM | Alenson Carman (1688865) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:42 PM | Prime Medicine (1894562) Issuer Reine Allan (1714023) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:42 PM | Cahill Thomas (1922939) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:43 PM | Chung Wendy (1922605) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:43 PM | Foster-Cheek Kaye I (1312622) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:43 PM | Kelly Michael Aaron (1769668) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:43 PM | Marrazzo Jeffrey D (1631262) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:43 PM | NELSEN ROBERT (1219042) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:43 PM | Prime Medicine (1894562) Issuer Schenkein David P (1578200) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2025 7:44 PM | LEE ANN L. (1723629) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/01/2025 6:18 PM | ARCH Venture Fund X Overage, L.P. (1757017) Reporting ARCH Venture Fund X, L.P. (1757011) Reporting ARCH Venture Partners X Overage, L.P. (1768905) Reporting ARCH Venture Partners X, L.P. (1782583) Reporting ARCH Venture Partners X, LLC (1769012) Reporting Burow Kristina (1569248) Reporting CRANDELL KEITH (1219039) Reporting GILLIS STEVEN (1229592) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/01/2025 6:19 PM | ARCH Venture Fund XII, L.P. (1906837) Reporting ARCH Venture Partners XII, L.P. (1979765) Reporting ARCH Venture Partners XII, LLC (1979548) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/01/2025 6:19 PM | NELSEN ROBERT (1219042) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/31/2025 4:14 PM | Prime Medicine (1894562) Filer | Form 424B5 | |
|
| 07/31/2025 4:16 PM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/14/2025 3:38 PM | Prime Medicine (1894562) Filer | Form DEF 14A | |
| 07/02/2025 3:44 PM | Prime Medicine (1894562) Filer | Form PRE 14A | |
| 06/23/2025 3:33 PM | Liu David R. (1664439) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 4:14 PM | Liu David R. (1664439) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:49 PM | Liu David R. (1664439) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:11 PM | Cahill Thomas (1922939) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:13 PM | Chung Wendy (1922605) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:13 PM | Foster-Cheek Kaye I (1312622) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:13 PM | Kelly Michael Aaron (1769668) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:13 PM | NELSEN ROBERT (1219042) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:13 PM | Marrazzo Jeffrey D (1631262) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 5:14 PM | Prime Medicine (1894562) Issuer Schenkein David P (1578200) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 3:18 PM | Prime Medicine (1894562) Issuer Reine Allan (1714023) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 3:21 PM | LEE ANN L. (1723629) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 3:22 PM | Brudnick Richard (1692359) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2025 6:44 PM | Prime Medicine (1894562) Issuer Reine Allan (1714023) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2025 6:45 PM | Marrazzo Jeffrey D (1631262) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2025 8:09 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2025 8:12 AM | Prime Medicine (1894562) Filer | Form DEFA14A | |
| 05/12/2025 3:48 PM | LEE ANN L. (1723629) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2025 3:50 PM | Gottesdiener Keith Michael (1615856) Reporting Prime Medicine (1894562) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2025 3:50 PM | Prime Medicine (1894562) Issuer Reine Allan (1714023) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2025 7:05 AM | Prime Medicine (1894562) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2025 7:08 AM | Prime Medicine (1894562) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |